Penumbra, Inc. (PEN)
338.72
+0.46
(+0.14%)
USD |
NYSE |
Feb 12, 16:00
338.82
+0.10
(+0.03%)
Pre-Market: 20:00
Penumbra Free Cash Flow : 152.62M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| Zimmer Biomet Holdings, Inc. | 1.420B |
| Globus Medical, Inc. | 569.94M |
| iRhythm Holdings, Inc. | 32.42M |
| Rapt Therapeutics, Inc. | -86.66M |